Search

everythinglearnresearchcommunity

for

Search:↓

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

New compounds were found to help increase hair growth and decrease hair loss.

The document's conclusion cannot be provided because the document is not readable or understandable.

The document's conclusion cannot be provided because the document is not readable or understandable.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

Dermoscopy helps accurately diagnose temporal triangular alopecia, avoiding unnecessary treatments.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Talquetamab may cause hair loss and skin issues.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Toe Tourniquet Syndrome is often misdiagnosed.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

The new hair product quickly reduces hair shedding in women.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

A new genetic mutation in the TRPS1 gene causes Trichorhinophalangeal Syndrome, leading to specific hair, dental, and bone issues.

The document's conclusion cannot be provided because the document is not accessible or understandable.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Some thymic peptides can increase human hair growth, while others may inhibit it.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document's conclusion cannot be provided because the document is not available or cannot be understood.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

A man developed an allergic skin reaction from a therapy cap used for hair loss treatment.

Pexidartinib often causes liver issues and fatigue, especially in women.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.